Symbols / ABCL Stock $4.77 -3.64% AbCellera Biologics Inc.

Healthcare • Biotechnology • Canada • NMS
ABCL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Carl L.G. Hansen Ph.D.
Exch · Country NMS · Canada
Market Cap 1.46B
Enterprise Value 1.09B
Income -143.96M
Sales 79.21M
FCF (ttm) -105.40M
Book/sh 3.22
Cash/sh 1.65
Employees 562
Insider 10d —
IPO Dec 11, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -6.62
PEG —
P/S 18.39
P/B 1.48
P/C —
EV/EBITDA -5.77
EV/Sales 13.71
Quick Ratio 11.45
Current Ratio 14.05
Debt/Eq 14.32
LT Debt/Eq —
EPS (ttm) -0.48
EPS next Y -0.72
EPS Growth —
Revenue Growth 96.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-11
ROA -9.99%
ROE -14.68%
ROIC —
Gross Margin -135.87%
Oper. Margin -6.92%
Profit Margin -181.74%
Shs Outstand 305.38M
Shs Float 205.32M
Insider Own 22.59%
Instit Own 41.58%
Short Float 18.88%
Short Ratio 8.75
Short Interest 44.46M
52W High 6.51
vs 52W High -26.78%
52W Low 1.94
vs 52W Low 145.88%
Beta —
Impl. Vol. 12.50%
Rel Volume 1.18
Avg Volume 4.99M
Volume 5.89M
Target (mean) $9.71
Tgt Median $10.00
Tgt Low $7.00
Tgt High $12.00
# Analysts 7
Recom Strong_buy
Prev Close $4.95
Price $4.77
Change -3.64%
About

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.71
Mean price target
2. Current target
$4.77
Latest analyst target
3. DCF / Fair value
$-6.21
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.77
Low
$7.00
High
$12.00
Mean
$9.71

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-05 init Cantor Fitzgerald — → Overweight $7
2026-04-10 init Jones Trading — → Buy $11
2025-11-07 down Leerink Partners Outperform → Market Perform $4
2025-08-08 main Stifel Buy → Buy $7
2025-07-14 main Keybanc Overweight → Overweight $10
2025-05-16 main Truist Securities Buy → Buy $10
2025-05-09 main Stifel Buy → Buy $8
2025-04-16 main Keybanc Overweight → Overweight $5
2025-03-03 reit Benchmark Hold → Hold —
2025-02-28 main Stifel Buy → Buy $10
2025-01-08 main Keybanc Overweight → Overweight $4
2024-11-05 reit Benchmark — → Hold —
2024-11-05 reit Stifel Buy → Buy $12
2024-08-20 down Benchmark Buy → Hold —
2024-07-11 main Keybanc Overweight → Overweight $5
2024-05-08 main Keybanc Overweight → Overweight $7
2024-02-22 up Benchmark Hold → Buy —
2024-02-21 main Stifel Buy → Buy $17
2023-12-05 init Keybanc — → Overweight $6
2023-08-31 main Benchmark Buy → Buy $12
News
RSS: Latest ABCL news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-27 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 38,000 $3.44 $130,720
2026-02-27 BOOTH ANDREW Chief Financial Officer — 42,600 $3.42 $145,692
2026-02-26 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 177,457 $3.27 $580,284
2025-12-18 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 225,000 $0.00 $0
2025-11-26 MONTALBANO JOHN S. Director — 50,000 $3.57 $178,460
2025-03-11 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 343,631 $2.16 $742,243
2025-03-10 MONTALBANO JOHN S. Director — 25,000 $2.30 $57,500
2025-03-06 MONTALBANO JOHN S. Director — 60,000 $2.34 $140,568
2024-12-04 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 286,000 $0.00 $0
2024-11-25 HANSEN CARL L.G. Chief Executive Officer — 56,125 $2.70 $151,538
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
75.13
+160.56%
28.83
-24.17%
38.02
-92.17%
485.42
Operating Revenue
75.13
+160.56%
28.83
-24.17%
38.02
-92.17%
485.42
Cost Of Revenue
—
0.00
0.00
-100.00%
66.44
Reconciled Cost Of Revenue
—
0.00
0.00
-100.00%
61.18
Gross Profit
—
28.83
-24.17%
38.02
-90.92%
418.99
Operating Expense
278.34
-15.65%
329.98
+26.39%
261.08
+36.03%
191.92
Research And Development
186.83
+11.70%
167.26
-4.78%
175.66
+62.83%
107.88
Selling General And Administration
83.23
-2.64%
85.49
+13.72%
75.18
+12.62%
66.75
Selling And Marketing Expense
—
12.78
-9.88%
14.18
+25.82%
11.27
General And Administrative Expense
—
72.71
+19.20%
61.00
+9.94%
55.48
Other Gand A
—
72.71
+19.20%
61.00
+9.94%
55.48
Other Operating Expenses
-13.89
-1.98%
-13.62
+3.78%
-14.15
-34.12%
-10.55
Total Expenses
278.34
-15.65%
329.98
+26.39%
261.08
+1.05%
258.36
Operating Income
-203.21
+32.52%
-301.15
-35.01%
-223.05
-198.23%
227.06
Total Operating Income As Reported
-217.10
+31.03%
-314.77
-32.70%
-237.21
-209.56%
216.51
EBITDA
-174.39
+14.58%
-204.15
-6.24%
-192.16
-173.86%
260.17
Normalized EBITDA
-174.39
+14.58%
-204.15
-6.24%
-192.16
-173.86%
260.17
Reconciled Depreciation
28.82
-70.29%
97.00
+213.97%
30.89
-6.67%
33.10
EBIT
-203.21
+32.52%
-301.15
-35.01%
-223.05
-198.23%
227.06
Total Unusual Items
—
—
—
—
Total Unusual Items Excluding Goodwill
—
—
—
—
Net Income
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Pretax Income
-177.59
+11.38%
-200.40
-15.15%
-174.03
-172.79%
239.10
Net Non Operating Interest Income Expense
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Interest Expense Non Operating
—
—
—
4.04
Net Interest Income
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Interest Expense
—
—
—
4.04
Interest Income Non Operating
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Interest Income
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Other Income Expense
-2.71
-104.35%
62.28
+819.10%
6.78
+267.52%
-4.04
Other Non Operating Income Expenses
-2.71
-104.35%
62.28
+819.10%
6.78
+267.52%
-4.04
Gain On Sale Of Security
—
—
—
—
Tax Provision
-31.18
+16.93%
-37.54
-35.85%
-27.63
-134.29%
80.58
Tax Rate For Calcs
0.00
-6.26%
0.00
+17.98%
0.00
-52.89%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income From Continuing Operation Net Minority Interest
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income From Continuing And Discontinued Operation
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income Continuous Operations
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Normalized Income
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income Common Stockholders
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-0.49
+10.91%
-0.55
-7.84%
-0.51
-202.00%
0.50
Basic EPS
-0.49
+10.91%
-0.55
-7.84%
-0.51
-191.07%
0.56
Basic Average Shares
298.71
+1.49%
294.33
+1.78%
289.17
+1.44%
285.06
Diluted Average Shares
298.71
+1.49%
294.33
+1.78%
289.17
-8.15%
314.83
Diluted NI Availto Com Stockholders
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Depreciation Amortization Depletion Income Statement
22.17
-75.60%
90.85
+272.41%
24.39
-12.38%
27.84
Depreciation And Amortization In Income Statement
22.17
-75.60%
90.85
+272.41%
24.39
-12.38%
27.84
Depreciation Income Statement
—
—
—
27.84
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,356.95
-0.26%
1,360.55
-8.57%
1,488.09
-3.43%
1,540.91
Current Assets
728.23
-3.08%
751.37
-13.83%
871.99
-14.97%
1,025.49
Cash Cash Equivalents And Short Term Investments
533.83
-14.67%
625.61
-17.75%
760.59
-14.20%
886.49
Cash And Cash Equivalents
128.51
-17.79%
156.32
+17.26%
133.32
-65.51%
386.54
Cash Equivalents
29.30
+0.34%
29.20
—
—
Cash Financial
99.30
-21.87%
127.10
—
—
Other Short Term Investments
405.31
-13.63%
469.29
-25.18%
627.26
+25.47%
499.95
Receivables
153.40
+66.50%
92.13
+43.10%
64.38
-37.74%
103.41
Accounts Receivable
58.29
+73.41%
33.62
+9.89%
30.59
-20.74%
38.59
Taxes Receivable
55.70
+109.90%
26.53
-21.48%
33.79
-47.87%
64.82
Loans Receivable
39.41
+23.24%
31.98
0.00
—
Inventory
6.34
0.00
-100.00%
1.11
-27.74%
1.53
Raw Materials
6.34
0.00
-100.00%
1.11
-27.74%
1.53
Prepaid Assets
—
—
—
9.06
Restricted Cash
25.00
+0.00%
25.00
+0.00%
25.00
+0.00%
25.00
Other Current Assets
9.67
+12.10%
8.63
-60.82%
22.02
+142.92%
9.06
Total Non Current Assets
628.72
+3.21%
609.18
-1.12%
616.11
+19.54%
515.42
Net PPE
428.00
+25.72%
340.43
+18.33%
287.70
+32.42%
217.25
Gross PPE
485.62
+27.74%
380.15
+19.43%
318.30
+35.03%
235.73
Accumulated Depreciation
-57.61
-45.06%
-39.72
-29.76%
-30.61
-65.67%
-18.48
Properties
0.00
0.00
0.00
0.00
Land And Improvements
53.41
+0.00%
53.41
+0.00%
53.41
+0.00%
53.41
Buildings And Improvements
193.16
+9.87%
175.81
+300.04%
43.95
+286.82%
11.36
Machinery Furniture Equipment
—
—
3.52
-57.64%
8.30
Other Properties
239.05
+58.38%
150.94
+2.67%
147.01
+20.41%
122.09
Leases
—
122.89
+66.20%
73.94
+82.28%
40.57
Goodwill And Other Intangible Assets
86.19
-4.15%
89.92
-46.55%
168.23
-6.18%
179.31
Goodwill
47.81
+0.00%
47.81
+0.00%
47.81
+0.00%
47.81
Other Intangible Assets
38.38
-8.86%
42.11
-65.03%
120.42
-8.42%
131.50
Investments And Advances
62.58
-23.96%
82.30
+24.81%
65.94
-9.08%
72.52
Long Term Equity Investment
62.58
-23.96%
82.30
+24.81%
65.94
-9.08%
72.52
Other Investments
—
—
—
—
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Non Current Prepaid Assets
—
—
—
—
Other Non Current Assets
51.95
-46.19%
96.54
+2.43%
94.24
+103.41%
46.33
Total Liabilities Net Minority Interest
390.05
+28.11%
304.47
-9.32%
335.78
+9.15%
307.63
Current Liabilities
64.31
-16.06%
76.61
-35.63%
119.01
+0.59%
118.32
Payables And Accrued Expenses
35.98
-29.18%
50.81
-41.45%
86.78
+2.29%
84.84
Payables
25.23
-40.55%
42.44
-46.34%
79.08
+0.88%
78.39
Accounts Payable
25.23
-26.56%
34.35
+20.09%
28.60
+92.90%
14.83
Other Payable
—
8.09
-83.98%
50.48
-20.58%
63.56
Current Accrued Expenses
10.76
+28.42%
8.38
+8.67%
7.71
+19.41%
6.45
Total Tax Payable
—
—
—
0.00
Income Tax Payable
—
—
—
0.00
Current Debt And Capital Lease Obligation
5.82
+25.84%
4.62
-24.96%
6.16
+10.30%
5.58
Current Capital Lease Obligation
5.82
+25.84%
4.62
-24.96%
6.16
+10.30%
5.58
Current Deferred Liabilities
22.51
+6.28%
21.18
-18.76%
26.07
-6.55%
27.90
Current Deferred Revenue
22.51
+6.28%
21.18
-18.76%
26.07
-6.55%
27.90
Other Current Liabilities
—
—
—
—
Total Non Current Liabilities Net Minority Interest
325.74
+42.96%
227.86
+5.12%
216.76
+14.50%
189.31
Long Term Debt And Capital Lease Obligation
137.40
+126.20%
60.74
-14.71%
71.22
-7.11%
76.67
Long Term Capital Lease Obligation
137.40
+126.20%
60.74
-14.71%
71.22
-7.11%
76.67
Tradeand Other Payables Non Current
—
0.00
-100.00%
4.91
-69.40%
16.05
Non Current Deferred Liabilities
183.57
+14.77%
159.94
+18.72%
134.72
+44.10%
93.50
Non Current Deferred Revenue
174.45
+16.39%
149.89
+43.98%
104.11
+72.60%
60.32
Non Current Deferred Taxes Liabilities
9.12
-9.32%
10.05
-67.16%
30.61
-7.73%
33.18
Other Non Current Liabilities
4.77
-33.49%
7.17
+21.39%
5.91
+91.38%
3.09
Stockholders Equity
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Common Stock Equity
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Capital Stock
802.34
+3.24%
777.17
+3.18%
753.20
+2.56%
734.37
Common Stock
802.34
+3.24%
777.17
+3.18%
753.20
+2.56%
734.37
Share Issued
300.60
+1.64%
295.76
+1.70%
290.82
+1.39%
286.85
Ordinary Shares Number
300.60
+1.64%
295.76
+1.70%
290.82
+1.39%
286.85
Additional Paid In Capital
198.28
+19.19%
166.36
+37.43%
121.05
+63.32%
74.12
Retained Earnings
-29.48
-125.21%
116.93
-58.21%
279.79
-34.35%
426.19
Gains Losses Not Affecting Retained Earnings
-4.23
+3.29%
-4.38
-154.53%
-1.72
-23.65%
-1.39
Other Equity Adjustments
-4.23
+3.29%
-4.38
-154.53%
-1.72
-23.65%
-1.39
Total Equity Gross Minority Interest
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Total Capitalization
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Working Capital
663.92
-1.61%
674.76
-10.39%
752.97
-17.00%
907.17
Invested Capital
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Total Debt
143.22
+119.11%
65.36
-15.53%
77.38
-5.93%
82.26
Capital Lease Obligations
143.22
+119.11%
65.36
-15.53%
77.38
-5.93%
82.26
Net Tangible Assets
880.72
-8.84%
966.16
-1.82%
984.09
-6.63%
1,053.97
Tangible Book Value
880.72
-8.84%
966.16
-1.82%
984.09
-6.63%
1,053.97
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-131.29
-20.95%
-108.56
-147.41%
-43.88
-115.82%
277.36
Cash Flow From Continuing Operating Activities
-131.29
-20.95%
-108.56
-147.41%
-43.88
-115.82%
277.36
Net Income From Continuing Operations
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Depreciation Amortization Depletion
28.82
-70.29%
97.00
+213.97%
30.89
-6.67%
33.10
Depreciation
25.09
+34.27%
18.69
-2.97%
19.26
+35.50%
14.21
Amortization Cash Flow
3.73
-95.23%
78.31
+572.96%
11.64
-38.40%
18.89
Depreciation And Amortization
28.82
-70.29%
97.00
+213.97%
30.89
-6.67%
33.10
Amortization Of Intangibles
3.73
-95.23%
78.31
+572.96%
11.64
-38.40%
18.89
Other Non Cash Items
1.20
+101.42%
-84.44
-1360.56%
-5.78
-189.86%
6.43
Stock Based Compensation
55.79
-17.44%
67.58
+5.29%
64.18
+29.71%
49.48
Deferred Tax
—
—
1.96
+192.72%
-2.11
Deferred Income Tax
—
—
1.96
+192.72%
-2.11
Change In Working Capital
-70.69
-173.55%
-25.84
-295.41%
13.22
-55.66%
29.82
Change In Receivables
-55.62
+25.95%
-75.12
-63.54%
-45.93
-143.15%
106.46
Changes In Account Receivables
-55.62
+25.95%
-75.12
-63.54%
-45.93
-102.21%
-22.71
Change In Payables And Accrued Expense
3.46
-67.49%
10.63
+170.41%
-15.10
-621.30%
-2.09
Change In Accrued Expense
—
—
—
-3.16
Change In Payable
—
—
-15.10
+82.75%
-87.54
Change In Account Payable
—
—
-15.10
-1516.89%
1.07
Change In Other Working Capital
-35.68
-209.14%
32.69
-41.64%
56.01
+176.55%
-73.16
Change In Other Current Assets
17.15
+188.01%
5.95
-67.38%
18.25
+1427.49%
-1.38
Change In Other Current Liabilities
—
—
—
-3.06
Investing Cash Flow
87.75
-27.72%
121.41
+154.91%
-221.11
+37.30%
-352.62
Cash Flow From Continuing Investing Activities
87.75
-27.72%
121.41
+154.91%
-221.11
+37.30%
-352.62
Net PPE Purchase And Sale
-42.77
+45.44%
-78.40
-1.88%
-76.95
-8.90%
-70.66
Purchase Of PPE
-42.77
+45.44%
-78.40
-1.88%
-76.95
-8.90%
-70.66
Capital Expenditure
-42.77
+45.44%
-78.40
-1.88%
-76.95
-5.90%
-72.66
Net Investment Purchase And Sale
52.94
-71.19%
183.72
+217.94%
-155.78
+42.46%
-270.72
Purchase Of Investment
-453.14
+40.77%
-765.09
+28.28%
-1,066.72
-36.52%
-781.35
Sale Of Investment
506.07
-46.66%
948.81
+4.16%
910.94
+78.39%
510.63
Net Business Purchase And Sale
-7.14
+63.63%
-19.63
-43.36%
-13.69
+46.69%
-25.68
Purchase Of Business
-7.14
+63.63%
-19.63
-43.36%
-13.69
+46.69%
-25.68
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-0.56
+72.00%
-2.00
Purchase Of Intangibles
—
0.00
+100.00%
-0.56
+72.00%
-2.00
Net Other Investing Changes
54.61
+52.94%
35.71
+41.08%
25.31
+54.02%
16.43
Financing Cash Flow
14.08
+10.28%
12.77
+23.30%
10.36
+736.12%
-1.63
Cash Flow From Continuing Financing Activities
14.08
+10.28%
12.77
+23.30%
10.36
+736.12%
-1.63
Net Issuance Payments Of Debt
—
—
11.59
+376.56%
2.43
Issuance Of Debt
—
—
11.59
+320.69%
2.75
Repayment Of Debt
—
—
—
-0.32
Long Term Debt Issuance
—
—
11.59
+320.69%
2.75
Long Term Debt Payments
—
—
—
-0.32
Net Long Term Debt Issuance
—
—
11.59
+376.56%
2.43
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
—
—
—
0.00
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
14.08
+10.28%
12.77
+23.30%
10.36
+736.12%
-1.63
Changes In Cash
-29.46
-214.99%
25.62
+110.06%
-254.63
-231.15%
-76.89
Effect Of Exchange Rate Changes
1.10
+141.92%
-2.62
-544.31%
0.59
+106.14%
-9.60
Beginning Cash Position
183.62
+14.32%
160.61
-61.27%
414.65
-17.26%
501.14
End Cash Position
155.25
-15.45%
183.62
+14.32%
160.61
-61.27%
414.65
Free Cash Flow
-174.07
+6.89%
-186.95
-54.73%
-120.82
-159.02%
204.70
Change In Income Tax Payable
—
—
—
-88.61
Change In Tax Payable
—
—
—
-88.61
Common Stock Issuance
—
—
—
0.00
Dividends Received CFI
30.11
0.00
0.00
—
Issuance Of Capital Stock
—
—
—
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category